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Introduction
Pediatric sepsis is the most common, deadly disease in both
the developing and developed world. Despite modern vac-
cines, antibiotics, and intensive care, the number of septic
patients rises year after year. However, sepsis still continues
to be themost frequently underdiagnosed entity. Timely and
appropriately started therapy is highly cost-effective,
whereas the 3-day mortality of untreated cases is 100%. In
light of all this, our fundamental goal is the early diagnosis of
sepsis.1–4
Sepsis is a clinical syndrome resulting from a systemic
inﬂammatory response (SIRS) evoked by severe infection.5
Physiological changes during SIRS are consequences of
pathological immune-dysregulation leading to inﬂamma-
tion, microcirculatory disturbance, abnormal vasodilation
or vasoconstriction, increased capillary permeability, and
abnormal white blood cell accumulation.
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Abstract Pediatric sepsis can be caused by infection agents such as viruses, bacteria, protozoa,
or their toxins. Clinical features cover a remarkably wide spectrum. Early recognition of
the disease and prompt initiation of therapy substantially improve mortality and the
outcome of potential complications. After an initial phase of very mild symptoms, the
spread of microbes or toxins in the bloodstream presents as septic shock through
vasoregulatory disturbance, absolute or relative intravascular volume loss, and con-
sequential tachycardia and hypotension. Themost common accompanying symptom is
fever. In physical examination, features such as altered mental status, excess respira-
tory effort, tachycardia, and prolonged capillary reﬁll time are present at an early stage
of the disease. Laboratory tests for the assessment of early stage severity and
subsequent monitoring of treatment efﬁcacy include point-of-care arterial blood gas
analysis and lactate assay. In early stage disease, it is imperative to promptly start
adequate antimicrobial and supportive treatment once bacterial cultures have been
taken. Despite the availability of a wide range of laboratory and imaging tests today,
diagnosis and severity assessment of sepsis still primarily rely on medical history and
clinical examination. In light of this, it is possible for trained care providers to detect the
early signs of a septic child during repetitive physical examinations. This is still the
mainstay of diagnosis and can provide in all care settings a signiﬁcant reduction in
therapeutic delay; this, in turn, helps to reduce sepsis-related mortality and morbidity.
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Although inﬂammation is vital in ﬁghting against infec-
tions, the immune response during sepsis is abnormal, with
the balance between pro- and anti-inﬂammatory mediators
disrupted, culminating in damage to the body and multiple
organ failure.6–12 Evidence exists that hereditary or acquired
immune deﬁciency may particularly misdirect the immune
response to pathogens, thus eliciting a more severe or more
rapidly progressing clinical manifestation.10
Age, vaccination and immunological status, medical his-
tory, and chronic diseases may help to identify vulnerable
patient groups.13–15
In establishing the diagnosis, the so-called systemic
inﬂammatory response syndrome (SIRS) criteria are help-
ful. Of course, SIRS may also develop as a reaction evoked by
other than pathogenic microorganisms. The conﬁrmation of
a noninfectious origin (e.g., trauma, burn, pancreatitis) may
be useful in avoiding inadequate antibiotic therapy. How-
ever, conﬁrmation of infection through microbiological
(blood, liquor, stool, or urine culture, polymerase chain
reaction [PCR]) or radiological (chest X-ray) means should
not delay initiation of adequate treatment (including
prompt antimicrobial therapy). A delay in diagnosis and
therapy signiﬁcantly increases mortality.14–17 It is also
important to assess initial mental status, respiratory func-
tion, intravascular volume status, and cardiac, hepatic,
renal, hematological, and coagulation functions since these
parameters may assist in ﬁnding the right level of therapy
aggressiveness with the goal to improve signiﬁcantly
prognosis.18–21
Diagnosis
We must remember, however, that even though countless
laboratory and imaging tests are available today, sepsis essen-
tially remains a clinical diagnosis. Even consensus criteria for
diagnosis of sepsis and septic shock may fail. Only two-third of
patients treated at intensive care units for severe sepsis or septic
shock satisﬁed the consensus criteria.22
The systemic inﬂammatory response syndrome, which
was ﬁrst introduced by the American College of Chest
Physicians and the Society of Critical Care Medicine, helps
us to detect the systemic inﬂammatory response, its severity,
and the choice of therapy.23–25 In 2005, the International
Pediatric Consensus Conference adapted the deﬁnition of
SIRS, sepsis, and related diagnoses to age-speciﬁc normal
values of childhood (►Tables 1–4).
However, clinical presentation, physical examination ﬁnd-
ings, and laboratory test results are neither speciﬁc nor
sensitive. Initial symptoms such as fever, cold chills, tachycar-
dia and elevated respiratory rate are too general and often
accompany merely a trivial viral infection. Prompt antibiotic
therapy started in general upon these symptoms would only
aggravate antibiotic resistance, a phenomenon already signif-
icantly observed worldwide. This may also cause unnecessary
hospitalizations, with ﬁnancial and social demands thereof.
On the other hand, starting therapy only after occurrence of
obvious clinical symptomssuch ashemodynamic instabilityor
altered mental status with impeding multiple organ failure
unequivocally results in drastically elevated mortality.
Table 1 Deﬁnitions of SIRS, infection, sepsis, severe sepsis, and septic shocka
SIRSa,c The presence of at least two of the following four criteria, one of which must be abnormal
temperature or leukocyte count:
Coreb temperature of >38.5°C or <36°C
Tachycardia, deﬁned as a mean heart rate >2 SD above normal for age in the absence of external
stimulus, chronic drugs, or painful stimuli, or otherwise unexplained persistent elevation over a
0.5- to 4-h period or for children<1 y old: bradycardia, deﬁned as amean heart rate<10th percentile
for age in the absence of external vagal stimulus, beta-blocker drugs, or congenital heart disease, or
otherwise unexplained persistent depression over a 0.5-h time period
Mean respiratory rate>2 SD above normal for age or mechanical ventilation for an acute process not
related to underlying neuromuscular disease or the receipt of general anesthesia
Leukocyte count elevated or depressed for age (not secondary to chemotherapy-induced leukopenia)
or >10% immature neutrophils
Infection A suspected or proven (by positive culture, tissue stain, or polymerase chain reaction test) infection
caused by any pathogen or a clinical syndrome associated with a high probability of infection.
Evidence of infection includes positive ﬁndings on clinical exam, imaging, or laboratory tests
(e.g., white blood cells in a normally sterile body ﬂuid, perforated viscus, chest radiograph consistent
with pneumonia, petechial or purpuric rash, or purpura fulminans)
Sepsis SIRS in the presence of or as a result of suspected or proven infection
Severe sepsis Sepsis plus one of the following: cardiovascular organ dysfunction or acute respiratory distress
syndrome or two or more other organ dysfunctions; organ dysfunctions are deﬁned in ►Table 2
Septic shock Sepsis and cardiovascular organ dysfunction as deﬁned in ►Table 2
Abbreviations: SD, standard deviation; SIRS, systemic inﬂammatory response syndrome.
aBased on data from Goldstein et al.5
bCore temperature must be measured by rectal, bladder, oral, or central catheter probe.
cSee ►Table 3 for age-speciﬁc ranges for physiological and laboratory variables.
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Due to the severe nature of this clinical diagnosis and the
potential for complications, all care providers should use a
readily available, simple, rapidly and multiply repeatable,
internationally accepted system of criteria with which dis-
ease progression and therapeutic efﬁcacy could be moni-
tored simply. Accepted in February 2016, the Third
International Consensus Deﬁnitions for Sepsis and Septic
Shock (Sepsis-3) are perfectly suitable for this.24
This article summarizes the most important objective
clinical parameters, thus facilitating early recognition of
sepsis.
Body Temperature
One of the key SIRS criteria is abnormal body temperature, be
it hyperthermia or hypothermia. Fever is an adaptive re-
sponse to infection. In vitro and animal experimental data
conﬁrm that cellular and humoral immunity shows in-
creased antimicrobial activity when temperature is higher.25
In children, the most frequent clinical sign of a septic
patient is a change in body temperature,mostly elevated core
temperature. When assessing central body temperature,
tympanic, rectal, urinary cystic, oral, or esophagealmeasure-
ment sites can be used. Today, the tympanic temperature is
most widely used during primary assessment.
Hypothermia is an independent prognostic factor in
sepsis mortality assessment. Adult studies report an in-
creased 90-day mortality when hypothermia develops dur-
ing sepsis. One-ﬁfth of septic patients are hypothermic at
hospital admission. The mortality of these patients is twice
as high, independent of age, disease severity, and concomi-
tant diseases.26–28 Relevant studies have found no under-
lying etiological or unambiguously abnormal immunological
Table 2 Organ dysfunction criteriaa
Cardiovascular dysfunction Despite administration of isotonic intravenous ﬂuid bolus 40 mL/kg in 1 h:
Decrease in BP (hypotension) 5th percentile for age or systolic BP < 2 SD below normal for age
or
Need for vasoactive drug to maintain BP in normal range (dopamine >5 µg/kg/min or
dobutamine, epinephrine, or norepinephrine at any dose)
or two of the following:
Unexplained metabolic acidosis: base deﬁcit >5 mEq/L
Increased arterial lactate more than two times upper limit of normal
Oliguria: urine output <0.5 mL/kg/h
Prolonged capillary reﬁll: >5 s
Core to peripheral temperature gap >3°C
Respiratory PaO2/FIO2 < 300 in the absence of cyanotic heart disease or preexisting lung disease
or
PaCO2 >65 Torr or 20 mm Hg over baseline PaCO2
or
Proven need or >50% FiO2 to maintain saturation >92%
or
Need for nonelective invasive or noninvasive mechanical ventilation
Neurologic Glasgow Coma Score < 11
or
Acute change inmental status with a decrease in Glasgow Coma Score3 points from abnormal
baseline
Hematological Platelet count of 80,000/mm3 or a decline of 50% in platelet count from highest value recorded
over the past 3 d (for chronic hematology/oncology patients)
or
International Normalized Ratio > 2
Renal Serum creatinine more than two times upper limit of normal for age or twofold increase in
baseline creatinine
Hepatic Total bilirubin < 4 mg/dL (not applicable for newborn)
or
ALT two times upper limit of normal for age
Abbreviations: ALT, alanine aminotransferase; BP, blood pressure; SD, standard deviation.
aGoldstein et al.5
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reasons. Elevated levels of fractalkine have been conﬁrmed in
hypothermia; it is a chemokine released upon endothelial cell
damage with a possible role in the ensuing vascular dysfunc-
tion, but its clinical signiﬁcance requires further research.26
Other studies on septic patients also reported increased
mortality and hypothermia-associated lymphopenia, which
is an early clinical predictor of sepsis-induced immunosup-
pression.29 Several studies reported on absolute leukocytope-
nia and lymphopenia in newborns receiving therapeutic
hypothermia for hypoxic–ischemic encephalopathy.30
Altered Mental Status
An important part of early assessment is the evaluation of
mental status. It is outstandingly important since it can be
performed right upon contact with the patient, with no need
for major physical, equipment-based or laboratory methods.
It also lends itself to continuous, noninvasive monitoring of
the mental status of the child.
In addition to the usual subjective description (irritability,
nervousness, disorientation, lethargy, somnolence, stupor,
coma), it can be continuously objectivized in real time using
the internationally recognized Glasgow Coma Scale. Inter-
estingly, in the emergency room, patients more frequently
presented with an altered mental status (38.2%) than with
excess of respiratory effort (30.2%).31 Clinical observations
indicate that Glasgow Coma Scale scores of 11 or less and
acute changes in mental status of at least two points are
correlated with disease severity. Changes in mental status
are affected by the general effects of inadequate tissue
oxygenation in the body, insufﬁcient tissue perfusion, po-
tential hypoglycemia, and signiﬁcant electrolyte distur-
bances. Of course, in septic events with an accompanying
central nervous system infection (i.e., meningoencephalitis),
local cerebral inﬂammation, circulation, and coagulation
disturbances may also alter mental status.
Respiratory System
The examination and continuous monitoring of the respira-
tory system is indispensable when dealing with septic
children. Strict observation and patency management of
the airways is a key factor to ensure gas exchange. Rapid
and objective assessment of the respiratory system is possi-
ble through tests such as age-speciﬁc respiratory rate, re-
spiratory effort, auscultation, transcutaneous oxygen
saturation, or blood gas analysis. Respiration rate is one of
the most sensitive indicators of disease severity.32
Surprisingly, respiratory alkalosis of a central origin is
often observable in early stage sepsis even before the onset of
metabolic acidosis. As the disease progresses, the release of
proinﬂammatory factors (cytokine storm) leads to a com-
promised lung compliance independent of age. In physical
examination, nasal ﬂaring, accessory respiratorymuscle use,
and appearance of suprasternal, subcostal, and sternal re-
tractions may indicate, even before laboratory tests, the
presence of acute lung injury (ALI) or the acute respiratory
distress syndrome (ARDS), which are frequent complications
conﬁrmable by radiological (ultrasound, chest X-ray) and
laboratory testing (arterial blood gas analysis).33 Peripheral
circulatory failure developing as the process continues,
coupled with the onset of metabolic acidosis as its conse-
quence, causes the respiratory rate to increase further, now
as a compensatory mechanism to maintain respiratory
alkalosis.
This compensatory mechanism is dedicated to two pos-
sible reasons. A substantial number of septic cases have
lower respiratory tract infection in the background, and
gas exchange is compromised due to the primary involve-
ment of the lungs. The most common cause of the afore-
mentioned ALI or ARDS is sepsis. Locally released
proinﬂammatory mediators are the underlying causes of
Table 3 Pediatric age groups for severe sepsis deﬁnitionsa
Newborn 0 d to 1 wk
Neonate 1 wk to 1 mo
Infant 1 mo to 1 y
Toddler and preschool 2–5 y
School age child 6–12 y
Adolescent and young adult 13 to <18 y
aGoldstein et al.5
Table 4 Age-speciﬁc vital signs and laboratory variablesa,b
Heart rate (beats/min) Respiratory
rate (breaths/min)
Leukocyte count
(leukocytes 103/mm3)
Systolic blood
pressure (mm Hg)Age group Tachycardia Bradycardia
0 d to 1 wk >180 <100 >50 >34 <65
1 wk to 1 mo >180 <100 >40 >19.5 or <5 <75
1 mo to 1 y >180 <90 >34 >17.5 or <5 <100
2–5 y >140 NA >22 >15.5 or <6 <94
6–12 y >130 NA >18 >13.5 or <4.5 <105
13 to <18 y >110 NA >14 >11 or <4.5 <117
aGoldstein et al.5
bLower values for heart rate, leukocyte count, and systolic blood pressure are for the ﬁfth and upper values for heart rate, respiration rate, or
leukocyte count for the 95th percentile.
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diffuse alveolar and pulmonary capillary injury, a process of
exudative nature in the early phase. This results in an
increased permeability of the alveolar–capillary barrier,
uponwhich the alveoli get ﬁlled upwith a protein-rich ﬂuid.
The process primarily affects type I pneumocytes. Type II,
surfactant-producing cells are more resilient against the
injury; however, damages to surfactant production lead to
further deterioration of lung compliance and atelectasis.
Neutrophils, tumor necrosis factor (TNF), various leuko-
trienes, macrophage inhibition factor, and other mediators
released during sepsis have a substantial role in the process.
The damaged alveolus collapses and is unable to reﬁll with
air at the next inspiration, thus escalating the ensuing
atelectasis. This results in an early loss of functional residual
capacity, an already limited resource in children, and, ﬁnally,
global respiratory failure occurs. To compensate for the loss
of lung compliance, accessory respiratory muscle effort is
necessary by increasing respiration minute volume.34–44
The excessive respiratory effort may require up to 40% of
the base metabolic rate and cardiac output. To avoid fatigue
and consequential cardiorespiratory collapse in children,
it is important to continuously monitor respiratory effort
by physical examination and noninvasive transcutaneous
saturation measurement, which is also informative of heart
rate. Continuous observation helps determine when and
how to start respiratory support, as well as facilitates close
therapeutic efﬁcacy monitoring once started.39,40,45–47
Cardiovascular System
Knowledge of age-speciﬁc heart rate, stroke volume, blood
pressure, and systemic vascular resistance values, as well as
their changes in response to the septic cascade triggered by
infectious agents is indispensable for disease recognition and
appropriate management. These are parameters with sub-
stantial differences between adults and various pediatric
groups.41–43
Clinically informative assessment of the cardiovascular
system also relies on a simultaneous evaluation of multiple
parameters. During diagnosis and for rapid monitoring of
therapeutic efﬁcacy, key markers include the physical ex-
amination of heart rate and capillary reﬁll time, and labora-
tory evaluation of arterial lactate levels and metabolic
acidosis. Assessment of the cardiovascular system is assisted
by noninvasive or invasive blood pressure measurement and
continuous urinary output monitoring.
The triad triggered by inﬂammatory response, that is, fever,
tachycardia, and altered vasoregulation, is a common set of
symptoms in incipient pediatric infection. Suspicionof a septic
event should be raised if these symptoms are accompanied by
altered mental status, irritability, disorientation, and dis-
turbed interpersonal contact. Similar to the respiratory sys-
tem, the basis for the process is abnormal inﬂammation and
dysregulation triggered and maintained by pathogens. The
mechanisms leading to cell damage are not yet fully under-
stood; however, postmortem data indicate a central role of
endothelial damage in the evolution of the process.
Provoked by the injury, abnormal vascular tone, increased
microvascular permeability, and leukocyte accumulation in-
itially lead to relative and then absolute intravascular ﬂuid
deﬁcit. Early symptoms of ﬂuid deﬁcit include an elevated
heart rate and increased capillary reﬁll timedue to poor tissue
perfusion. Owing to compensatory mechanisms, blood pres-
sure drop is a late-onset symptom in most pediatric cases,
together with reduced urinary output (< 1 mL/kg/hour).
Heart Rate
Similar to respiratory rate, heart rate values are strongly
age-speciﬁc. Changes in heart rate are a nonspeciﬁc sign,
but it is a highly sensitive early stage indicator of relative or
absolute ﬂuid deﬁcit, a common accompanying feature of
pediatric shock; it is also one of the mechanisms to com-
pensate for ongoing cardiac dysfunction or altered vascular
resistance.43
Heart rate variability (HRV) is an indicator of the heart’s
neurovegetative activity and autonomous function. It de-
scribes the heart’s ability to continuously vary the time
interval from heartbeat to heartbeat (RR interval) in re-
sponse to changes in internal and external environmental
demand; it is thus a measure of cardiac adaptability. Neither
its etiology nor its exact clinical signiﬁcance is clear yet;
however, reduced HRV shows an association with poor out-
comes in septic patients. HRVcan predict the development of
septic shock and multiple organ failure in sepsis.44,48–51 In
newborns, it predicts blood culture positive septic cases
independent of laboratory ﬁndings.52–54 An association is
also detectable between hypercytokinemia, elevated inter-
leukin (IL)-6, levels and reduced HRV in septic patients.55
Further research is needed to clarify the exact mechan-
isms of abnormal HRV and autonomous nervous system
disorders.56–58
Tissue Perfusion
Microcirculation is the most important target in the septic
process. Reduction in the number of functioning capillaries
compromises oxygen utilization.
Several approaches exist to assess damaged microcircula-
tion. The simplest, quickest, and most reproducible one is the
measurement of capillary reﬁll time. A capillary reﬁll time of
longer than 3 seconds is regarded as abnormal and prolonged.
Additional signs of disturbed microcirculation include
altered skin temperature and skin color (paleness, mottling).
Prolonged capillary reﬁll time in incipient sepsis is a reliable
indicator of vital organ microcirculation.
There are, of course, equipment-based tests available to
assess the process. Spectrophotometry and sublingual/gas-
tric assessment of orthogonal spectral polarization have not
been established in daily routine diagnostics.59–63
Based on changes in hemodynamic response, cardiac
output, and systemic vascular resistance, two forms of shock
can be distinguished.64
Clinical manifestation may identify shock as being of the
warm (hyperdynamic) type, characterized by low systemic
vascular resistance, quick and prompt capillary reﬁll time,
warm skin all over the body, Corrigan’s pulse, andwide pulse
pressure (difference between systolic and diastolic blood
pressure).
Journal of Child Science Vol. 1 No. 1/2017
Pediatric Sepsis: Clinical Markers Szima et al.e46
Children’s heart rates are physiologically higher than
those of adults. So there is much less opportunity to further
increase heart rate as a compensatory mechanism than in
adults. Children therefore tend to raise their systemic vas-
cular resistance in response to blood pressure decrease and
to maintain it in the normal range.
In cold (hypodynamic) shock, systemic vascular resis-
tance is high, the skin is cold and damp, a so-called cold-
warm boundary can be detected, the capillary reﬁll time is
prolonged, the pulse is suppressible, and the pulse ampli-
tude is narrow. There is, of course, a limit beyond which
further vasoconstriction leads to a decrease in cardiac
output, hypotension, circulatory failure, and eventually
death, unless appropriate intervention is made. Earliest
possible recognition and treatment of cold shock persisting
in spite of normal blood pressures is therefore a key out-
come factor.65
Tissue perfusion, capillary reﬁll time, and cold–warm
boundary assessment are excellent markers in both shock
severity evaluation and therapeutic efﬁcacy monitoring.66–71
Blood Pressure
Blood pressure drop is a very late-phase manifestation in
pediatric shock; therefore, normal age-speciﬁc blood pres-
sure values early in the process do not help to exclude the
diagnosis. They do help, however, differentiate between cold
and warm shock in a noninvasive way. Treatment goals
include restoring an age-speciﬁc normal blood pressure
within the golden hour. Each hour spent outside the age-
speciﬁc normal blood pressure range and with a capillary
reﬁll time of at least 3 seconds will double the mortality.72
Various hemodynamic values measured at emergency
departmentsare characterizedbyvariousmortalityestimates:
normal heart rate, 1%; tachycardia/bradycardia, 3%; hypoten-
sion and capillary reﬁll time <3 seconds, 5%; normotension
and prolonged capillary reﬁll time, 7%; hypotension and
prolonged capillary reﬁll time, 33%. When hemodynamic
values are normalized by treatment based on ACCM/PALS
(American College of Critical Care Medicine-Pediatric
Advanced Life Support) guidelines, a 40% reduction in mortal-
ity canbe observed, independentof thepatient’s group assign-
ment at treatment initiation.40,73
Subcutaneous Bleeding
Skin changes, that is, color and temperature described pre-
viously, mainly depend on shock type. In either type, throm-
bocytopenia developing as part of the septic process causes
petechiae, and an early physical symptom of disseminated
intravascular coagulation is the appearance of purpura. All
patients developing purpurae should be considered poten-
tially severe cases. When suspecting invasive meningococcal
infection, parenteral antibiotic treatment must be started
immediately, even before arrival at the hospital.
Likewise, upon detection of grave thrombocytopenia,
extensive, cause-ﬁnding examinations and coagulation tests
must be performed.
Sepsis-induced disseminated intravascular coagulation
may result in complement-mediated thrombotic microan-
giopathy. The process may culminate in necrotizing fasciitis
requiring a surgical solution.74–76
The most severe manifestation of the process is purpura
fulminans, a life-threatening condition characterized by
disseminated dermal and systemic thrombosis, skin bleed-
ing and dermal necrosis, systemic microcirculation disorder,
andmultiple organ failure. The pathogenesis of the process is
rooted in intrinsic coagulation cascade disorders and her-
editary or acquired protein C deﬁciency.77–80
Laboratory Investigations
Owing to the nature of the septic process, laboratory tests are
run in parallel with treatment initiation while diagnosis is
still being established. In full-blown septic shock, antimi-
crobial treatment and golden-hour therapy must not be
delayed by laboratory tests (blood panel, inﬂammatory
parameters, liver and kidney function tests).
Microbiology
Microbiological tests should take place before the onset of
antimicrobial treatment, if possible, but must in no way
cause signiﬁcant delay (longer than 45 minutes).
It is recommended to collect an aerobic and an anaerobic
blood culture sample from at least one sampling site, but
preferably from twodifferent sampling sites.81–85 Fromolder
children, volumes of 3 to 10 mL should be sampled, which
reduces incidence of false-negative cases.86–96
In addition to conventional microbiological diagnosis, an
alternative way of pathogen identiﬁcation is PCR. Multiple
PCR is well-known to deliver faster results, but requires a
greater volume of blood, and is more prone to false-positive
results and does not facilitate antibiogram assessment.96–102
White Blood Cell Count
Age-speciﬁc white blood cell count deviations and a percen-
tage of immature forms higher than 10% are included in SIRS
criteria as well. In suspicion of sepsis, the most fundamental
laboratory test is total white blood cell count. Bacterial
infection may entail both neutrophilia and neutropenia.
The greater the proportion of immature white blood cells,
the greater the chance of an infectious origin behind SIRS.103
Inﬂammatory Markers
Additional inﬂammatory markers recommended for use are
sedimentation rate, C-reactive protein, IL-1b, IL-6, IL-8, TNF-α,
leukotriene B4, and procalcitonin (PCT). Because early disease
symptoms are nonspeciﬁc, combined use of biomarkers is
recommended for quick diagnostic judgment, rapid treatment
initiation, and therapeutic efﬁcacy monitoring, thereby sig-
niﬁcantly improving speciﬁcity and sensitivity.103–106
Inﬂammatory marker assessment is useful in predicting
severe bacterial infection in infants and children with
no clinically deﬁnite focal infectious lesions on hospital
admission.107,108
In children aged 2 to 17 years, combined use of metabolic
and inﬂammatory parameters helps identify patients who
require intensive care. Information on multiple laboratory
parameters is especially helpful in determining disease
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severity also in situations where care providers are less
experienced in pediatric care.109
PatientswhosatisfySIRS criteria andhaveelevated IL-6 levels
are more likely to develop complications (pneumonia, multiple
organ failure) and have a greater mortality risk.110 On the other
hand, declining levels are agood indicatorof therapeuticefﬁcacy
as early as day 2 of antibiotic treatment and have a positive
predictive value in SIRS with an infectious origin.111
The soluble form of the CD14 cellular surface antigen is
called presepsin (P-SEP). CD14 is a diagnostic and prognostic
marker in adult sepsis. According to a prospective study,
P-SEP in late-onset sepsis of premature babies is a potentially
useful biomarker in both establishing diagnosis and treat-
ment monitoring.105
Repeat assessment of markers with various half-lives
helps conﬁrm diagnosis and is suitable for disease activity
monitoring; on a longer run, it also assists in judging the
duration of antimicrobial therapy. PCT is more likely to help
distinguish betweenviral and bacterial pathologies, but has a
limited signiﬁcance in determining the septic process in
children as compared with adults.103,106–121
Platelet Count and Hemostasis
Disseminated intravascular coagulation developing during
sepsis is affected not only by basic coagulation factors but
also by endothelial injury caused by thrombocytes and
proinﬂammatory factors. Coagulation system assessment
is imperative in critically ill patients. The most important
tests include platelet count, partial thromboplastin time,
international normalized ratio, and activated partial throm-
boplastin time.
In sepsis, thrombocytopenia is well correlated with dis-
ease severity and is an early predictor of poor outcomes. Of
various other biomarkers, elevated levels of soluble throm-
bomodulin were associated with higher 90-day mortality
and multiple organ failure.
Endothelial injury and consequential coagulopathy play a
central role in sepsis pathogenesis and facilitate prognostic
judgment.122–130
Acid–Base Tests
In critically ill patients, themost common bedside laboratory
test is blood–gas analysis to assess acid–base homeostasis. If
we deﬁne sepsis as a malignant intravascular inﬂammatory
reaction, it is easy to see how an uncontrolled release of
inﬂammatory mediators and complement activation lead to
tissue oxygen deﬁcit and consequential metabolic acidosis
through increased oxygen consumption due to alteredmeta-
bolic autoregulation and through reduced oxygen availabil-
ity.131 The process is only aggravated by microcirculatory
and endothelial dysfunction, and an initially relative, and
later absolute, ﬂuid deﬁcit. Testing for pH and base deﬁcit
provides a quick and easy-to-represent picture of the body’s
metabolic status and therapeutic efﬁcacy.
Lactate
Tissue lactate assessment is a good indicator of both appro-
priate tissue supply and aerobic glucose utilization. Elevated
lactate levels are a good predictor of shock and tissue hypo-
perfusion even in normotensive patients. In suspicionof septic
shock, it is recommended to test for lactate level at the time of
diagnosis because it is known to be elevated in early stage
shock. It is an excellent therapy monitoring marker; in the
presence of elevated levels, therapeutic objectives include
restoring a physiological lactate level.132–134
Pediatric evidence is limited, but one study has found that
children satisfying SIRS criteria and having avenous lactate level
greater than 4 mmol/L at diagnosis are more likely to develop
organ dysfunction in the ﬁrst 24 hours of treatment.135
Blood Glucose
Blood glucose testing is of fundamental importance in all
critically ill children. Hypoglycemia, especially in infants, can
be explained by alteredmetabolic utilization and a decline in
enteral intake due to a poor general condition. Hypoglyce-
mia, of course, needs immediate correction to avoid potential
harmful neurologic outcomes. On the other hand, a disturbed
glucose homeostasis, peripheral insulin resistance, and
stress hormone release can lead to hyperglycemia as
well.136,137 Stress-induced hyperglycemia has been reported
in cases of meningococcemia.138,139
Both hypoglycemia and hyperglycemia have been reported
to be associated with higher mortality in newborns.140 Since
a correlation exists between hypercytokinemia and blood
glucose levels in septic patients, adequate glycemic control
is important during therapy. Under tight control, it is pos-
sible to avoid hypoglycemia induced by intensive insulin
therapy.141–143
Calcium
Intracellular calcium has a major role in maintaining vascu-
lar tone and also affects myocardial function. Its assessment
is important in any shock processes including septic shock.
Reduced calcium levels are a frequent symptom in critically
ill patients, most likely due to hormonal milieu alterations,
but with a pathophysiology not yet fully understood.144–146
In sepsis, reduced calcium levels may contribute to a de-
creased myocardial function.147,148 Upon detecting a low
ionized calcium level (< 1.1 mmol/L) or symptomatic hypo-
calcemia (positive Chvostek or Trousseau sign, spasms, pro-
longed QT interval) during the septic process, immediate
correction of the hypocalcemia is recommended.45,149
Conclusion
In summary, sepsis continues to play a signiﬁcant role in
childhood mortality today. In developed countries, a half of
all premature and newborn mortality is originated from this
disease. Sepsis mortality declines as children get older. Its
signiﬁcance is made even greater by a potential for serious
long-term consequences in survivors due to tissue perfusion
disturbance and subsequent multiple organ failure. Estab-
lishing the diagnosis of sepsis is not simple in any age.
However, the nature of the process classiﬁes it as what we
call a time-factor disease, making sepsis diagnosis and
treatment a real emergency task. Early recognition is the
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ﬁrst step down the road toward reducedmortality rates. This
requires continuous education of patients and their relatives
to recognize early warning signs in vulnerable populations.
Despite the availability of a wide range of laboratory, micro-
biological, and imaging tests today, sepsis continues to be a
primarily clinical diagnosis. Medical history and a thorough
physical examination are indispensable for diagnostic judg-
ment. Owing to the dynamic nature of sepsis pathophysiol-
ogy, evaluation and reevaluation of physical examination
ﬁndings and bedside laboratory tests are indispensable not
only in early diagnosis but also in controlling the therapeutic
process. Most importantly, sepsis must be kept in mind as a
potential diagnosis in almost every child in the emergency
room when an infection cannot be excluded.
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